All lobbying filings

MEDLINE

Lobbying for MEDLINE · Medical product manufacturing and distribution

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $400,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 13

HR 2005
DMEPOS Relief Act of 2025
S 2951
Competitive Bidding Relief Act
HR 1703
Choices for Increased Mobility Act of 2026
S 247
Choices for Increased Mobility Act of 2025
HR 2902
SOAR Act of 2025
S 1406
SOAR Act of 2025
S 4037
Diabetes Act
S 4384
Medicare Advantage Improvement Act of 2026
HR 8375
Medicare Advantage Improvement Act of 2026
S 4641
Improving Access to Medicare Coverage Act of 2026
HR 3954
Improving Access to Medicare Coverage Act of 2025
S 4467
Ensuring Seniors’ Access to Quality Care Act
HR 7096
Ensuring Seniors’ Access to Quality Care Act

Lobbying activity 2

Health Issues

Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)

Trade (domestic/foreign)

Issues related to tariffs and healthcare supply chain

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.